Biometric Identity and Authentication Provider BIO-key to host Q1’26 Investor Webcast Monday, May 18th at 10am ET
Rhea-AI Summary
BIO-key (NASDAQ: BKYI) will host its Q1’26 investor call and webcast on Monday, May 18th at 10 a.m. ET. Chairman & CEO Mike DePasquale and CFO Cecilia Welch will lead the presentation and Q&A.
The event includes phone dial-in, live webcast, and a three-month replay.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – BKYI
On the day this news was published, BKYI declined 34.84%, reflecting a significant negative market reaction. Argus tracked a trough of -29.7% from its starting point during tracking. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $4.35M at that time. Trading volume was exceptionally heavy at 5.1x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Momentum scanner flags the target as moving down while three peers (e.g., VRME, KSCP, BAER) are moving up, suggesting stock-specific trading rather than a sector-wide move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 28 | Reverse stock split | Negative | -14.3% | Announced 1-for-10 reverse split to support Nasdaq minimum bid compliance. |
| Apr 22 | Nasdaq notice | Negative | -5.5% | Received Nasdaq non-compliance notice for delayed Form 10-K filing. |
| Apr 16 | Revenue/profit outlook | Positive | +6.3% | Guided to ~50% 1H 2026 revenue growth and a swing to profitability. |
| Mar 31 | 2025 results, outlook | Negative | -11.3% | Reported lower 2025 revenue but stronger cash and projected 37% Q1’26 growth. |
| Mar 25 | Investor call notice | Neutral | +6.3% | Announced 2025 year-end investor call with webcast and replay details. |
Recent news shows price declines on structural and compliance items (reverse split, Nasdaq notice) and gains on growth/profitability messaging, with one prior investor-call announcement drawing a positive move.
Over the last few months, BIO-key has focused on balance sheet repair and listing compliance while signaling improving operations. A 1-for-10 reverse split and Nasdaq non-compliance notice weighed on the stock, while guidance for a 50% first-half revenue increase and expected profitability in 1H 2026 supported positive reactions. Prior call announcements, like the March 31, 2026 year-end investor call, also saw constructive trading. Today’s Q1’26 webcast notice fits this pattern of regular investor communications around operational updates.
Market Pulse Summary
The stock dropped -34.8% in the session following this news. A negative reaction despite this routine webcast notice would fit a pattern where structural and compliance concerns have overshadowed otherwise neutral or positive catalysts. The shares remained far below their 52-week high and recently completed a 1-for-10 reverse split, which previously saw a -14.32% move. Such a backdrop can amplify downside when investors focus on balance sheet, listing status, or governance risks.
Key Terms
identity and access management (iam) technical
biometric authentication technical
multi-factor technical
on-premise technical
AI-generated analysis. Not financial advice.
HOLMDEL, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its Q1’26 investor call and webcast on Monday, May 18th at 10 a.m. ET. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the call and Q&A session.
| Call/Webcast Details | |
| Date / Time: | Monday, May 18th at 10 a.m. ET |
| Call Dial In #: | 1-877-418-5460 U.S. or 1-412-717-9594 Int’l |
| Live Webcast / Replay: | Webcast & Replay Link – Available for 3 months. |
| Audio Replay: | 1-855-669-9658 U.S. or 1-412-317-0088 Int’l; code 1165470 |
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key provides phoneless, tokenless, and passwordless biometric options, enabling customers to choose the right authentication factors for their diverse use cases. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
| Engage with BIO-key | |
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: | @BIO_keyIR |
| StockTwits: | BIO_keyIR |
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
